Operating Income (Loss) in USD of AbCellera Biologics Inc. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
AbCellera Biologics Inc. quarterly/annual Operating Income (Loss) history and change rate from 2019 to Q3 2025.
  • AbCellera Biologics Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$76.3M, a 18.6% increase year-over-year.
  • AbCellera Biologics Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$261M, a 15.2% increase year-over-year.
  • AbCellera Biologics Inc. annual Operating Income (Loss) for 2024 was -$315M, a 32.7% decline from 2023.
  • AbCellera Biologics Inc. annual Operating Income (Loss) for 2023 was -$237M, a 210% decline from 2022.
  • AbCellera Biologics Inc. annual Operating Income (Loss) for 2022 was $217M, a 5.92% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

AbCellera Biologics Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$261M -$76.3M +$17.4M +18.6% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$279M -$49.6M +$43.9M +46.9% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$323M -$62.7M -$7.77M -14.1% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$315M -$72.8M -$6.7M -10.1% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025
Q3 2024 -$308M -$93.7M -$38.8M -70.6% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$269M -$93.5M -$42.1M -81.9% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$227M -$54.9M +$9.98M +15.4% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$237M -$66.1M -$28.3M -74.8% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 -$209M -$54.9M -$92.6M -245% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024
Q2 2023 -$116M -$51.4M -$43M -512% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 -$73.3M -$64.9M -$290M -129% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 $217M -$37.8M -$119M -146% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025
Q3 2022 $336M $37.7M +$65.8M 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023
Q2 2022 $270M -$8.4M -$1.36M -19.4% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 $271M $225M +$66.9M +42.3% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 $204M $81.5M -$79.3M -49.3% 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024
Q3 2021 $284M -$28.1M -$26.3M -1489% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 $310M -$7.03M -$6.18M -724% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $316M $158M +$160M 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 $156M $161M 01 Oct 2020 31 Dec 2020 10-K 21 Feb 2023
Q3 2020 -$1.77M 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$854K 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 -$2.12M 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021

AbCellera Biologics Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$315M -$77.6M -32.7% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025
2023 -$237M -$454M -210% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025
2022 $217M +$12.1M +5.92% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025
2021 $204M +$48.4M +31% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024
2020 $156M +$160M 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023
2019 -$4.12M 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.